USPTF Recommendations for Statins as primary prevention of CV disease
At Statins as Primary Prevention @ יואל קסלר .com we are presenting newly released data from the United States Preventative Task Force on the use of statin medications as primary prevention of cardiovascular disease.
Task Force Issues Draft Recommendation Statement on Statin Use for the Primary Prevention of Cardiovascular Disease in Adults
The U.S. Preventive Services Task Force posted a draft recommendation statement on the use of statins to prevent heart disease and stroke, also known as cardiovascular disease (CVD). People ages 40 to 75 who are at high risk for CVD should take a statin to prevent a first heart attack or stroke. This is a B grade. People ages 40 to 75 who are at increased risk, but not at high risk, for CVD may benefit from statin use and should decide with their clinician if taking a statin is right for them. This is a C grade. More research is needed on whether people 76 or older should start taking a statin. This is an I statement. These recommendations only apply to people without a history of CVD and who are not already taking statins. The full press release from the organization can be found here.
How were the conclusions reached?
The researchers found that in the 40 to 75 year old age group that statin therapy was associated with a reduced risk for all-cause mortality, stroke, myocardial infarction, and composite cardiovascular outcomes (risk ratios, 0.92, 0.78, 0.67, and 0.72, respectively) Statin use in this group was not associated with an increased risk of diabetes, liver injury, or myalgia.